| New Horizons in Reducing Cardiovascular Disease Risk in Patients with Type 2 Diabetes with SGLT-2, GLP-1 RAs and DPP-4 Based Therapies Released on 6/14/19 Expires on 6/14/20 Link to webcast |
| Changing Landscape of GLP-1 Receptor Agonists on Glycemic Control, Weight Reduction and Cardiovascular Outcomes in Individuals with Diabetes Released on 6/12/19 Expires on 6/12/20 Link to webcast |
| Changing Landscape of Treatment Options for Migraine with Monoclonal Antibodies Targeting Calcitonin Gene-related Peptide (CGRP) Pathway or its Receptor Released on 3/22/19 Expires on 3/22/20 Link to webcast |
| Emerging Newer Therapies in the Management of Lung Function, Exacerbations, Safety and Tolerability in Patients with COPD Released on 8/9/18 Expires on 8/9/19 Link to webcast |
| Emerging Anti-Interleukin 5 (IL-5) and IL-5Ra Based Biological Therapies: Efficacy, Safety and Future Perspectives in Severe Eosinophilic Asthma Released on 7/12/18 Expires on 7/12/19 Link to webcast |
| Emerging Interleukin-5 (IL-5) or its Receptor (IL-5R) Monoclonal Antibody Based Biological Therapies for Severe or Poorly Controlled Asthma Released on 6/29/18 Expires on 6/29/19 Link to webcast |
| Emerging Strategies in the Diagnosis and Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) Released on 6/19/18 Expires on 6/19/19 Link to webcast |
| New Era in the Lipid Lowering Treatment with PCSK9 Inhibitors (Evolocumab and Alirocumab) in Patients with Atherosclerotic Cardiovascular Disease and Familial Hypercholesterolemia Released on 5/11/18 Expires on 5/11/19 Link to webcast |
| Emerging Strategies in the Diagnosis and Treatment of Interstitial Lung Disease (ILD) Released on 5/10/18 Expires on 5/10/19 Link to webcast |
| Emerging Strategies in the Anti–Interleukin-5 Monoclonal Antibody Based Targeted Therapies for Eosinophilic Granulomatosis with Polyangiitis (EGPA) Released on 2/6/18 Expires on 2/6/19 Link to webcast |
| Efficacy and Safety of Fixed-ratio Combination of Insulin Degludec and Liraglutide (IDegLira) and Insulin Glargine and Lixisenatide (IGlarLixi) in Patients with Type 2 Diabetes Released on 11/29/17 Expires on 11/29/18 Link to webcast |
| Emerging Strategies in the Monoclonal Antibodies Targeting Calcitonin Gene-related Peptide (CGRP) or its Receptor in the Preventive Treatment of Migraine Released on 11/17/17 Expires on 11/17/18 Link to webcast |
| Emerging Strategies in the Management of Dyslipidemia in Patients with Atherosclerotic Cardiovascular Disease and Familial Hypercholesterolemia: PCSK9 Inhibitors (Evolocumab and Alirocumab) Released on 10/10/17 Expires on 10/10/18 Link to webcast |
| Changing Landscape of Biological Therapies for Psoriasis: Promising Efficacy of Interleukin-17 (IL-17) and IL-2 Pathway Inhibitors Released on 9/20/17 Expires on 9/20/18 Link to webcast |
| Advances in Biological Therapy of Crohn's Disease and Ulcerative Colitis Released on 8/10/17 Expires on 8/10/18 Link to webcast |
| Emerging Immunotherapeutic Strategies for Poorly Controlled Asthma Released on 7/20/17 Expires on 7/20/18 Link to webcast |
| Advances in GLP-1 Receptor Agonists, Insulins and SGLT-2 Inhibitors in the Treatment of Diabetes Released on 5/12/17 Expires on 5/12/18 Link to webcast |
| Individualized Treatment Options for Type 2 Diabetes: Comparative Effectiveness of GLP-1 Receptor Agonists on Glycemic Control, Weight Reduction and Cardiovascular Risk Released on 4/20/17 Expires on 4/20/18 Link to webcast |
| Emerging Strategies in the Treatment of Parkinson's Disease: Management of Non-Motor, Motor and Psychotic Symptoms Released on 2/24/17 Expires on 2/24/18 Link to webcast |
| Emerging Biological Therapies for Atopic Dermatitis in Children and Adults Released on 2/15/17 Expires on 2/15/18 Link to webcast |
| Biological Therapies for PsA, Osteoarthritis, SLE and Spondyloarthritis: Comparative Effectiveness Based on Treatment Profiles and ACR/EULAR Recommendations Released on 12/15/16 Expires on 12/15/17 Link to webcast |
| Emerging Interleukin5 (IL5) Antagonists Based Therapies for Eosinophilic Asthma Released on 10/31/16 Expires on 10/31/17 Link to webcast |
| Emerging Biological Therapies for Psoriasis: Promising Efficacy of Interleukin‐17 (IL‐17) and IL‐23 Pathway Inhibitors Released on 10/28/16 Expires on 10/28/17 Link to webcast |
| 3rd Annual Symposium on Individualized Novel Disease-Modifying Treatment Options for Multiple Sclerosis Released on 10/26/2016 Expires on 10/26/2017 Link to webcast |
| Update on Novel Antiepileptic Drugs in Treatment of Epilepsy Released on 9/28/16 Expires on 9/28/17 Link to webcast |
| Emerging Immunotherapeutic Strategies for Poorly Controlled Asthma Released on 7/20/2016 Expires on 7/20/2017 Link to webcast |
| Update on GLP-1 Receptor Agonists in the Management of Type 2 Diabetes Mellitus Released on 7/7/16 Expires on 7/7/17 Link to webcast |